Quetiapine vs olanzapine: sedation, weight, and when each is chosen

If you go by raw prescription numbers, quetiapine (Seroquel) and olanzapine (Zyprexa) are two of the most familiar atypical antipsychotics in the world. Both are sedating, both can drive significant weight gain, and both are licensed across schizophrenia and bipolar disorder. Yet despite the surface similarities, their evidence bases, dosing logic, and typical clinical roles diverge in ways that matter to patients trying to understand their options.

Receptor profiles

Both bind a wide range of receptors. Olanzapine has stronger and more selective dopamine D2 blockade, plus 5-HT2A, H1, M1, and alpha-1. Quetiapine's profile is dominated by very strong H1 (histamine) blockade — driving its sedating effect — and only modest D2 activity except at high doses. This explains a few practical differences:

• Quetiapine is far more sedating per milligram
• Quetiapine requires much higher doses (300–800 mg) to achieve antipsychotic-level D2 occupancy
• Olanzapine is a stronger antipsychotic per milligram but more uniformly affects multiple symptom domains

Efficacy: the trial evidence

The CATIE trial (NIMH, 2005) is the most direct comparison. Among the second-generation arms, olanzapine had significantly longer time-to-discontinuation than quetiapine, risperidone, ziprasidone, or perphenazine. Patients on olanzapine were more likely to remain on it for the full 18-month protocol; patients on quetiapine were more likely to discontinue for inadequate efficacy.

Network meta-analyses (Leucht et al., Lancet 2013; PubMed) place olanzapine in the top tier of atypical efficacy, with quetiapine consistently behind it in symptom reduction and relapse prevention.

For bipolar depression, however, quetiapine has stronger and more specific evidence — it is one of the few medications with FDA approval for this challenging indication, while olanzapine's bipolar-depression approval is for the combination product Symbyax (with fluoxetine).

Side effects compared

Weight and metabolic burden

Olanzapine is consistently among the heaviest atypicals on weight gain (5–8 kg average year-one). Quetiapine is lighter than olanzapine but still substantial (2–5 kg average), and it has a similar pattern of metabolic risk — diabetes, dyslipidaemia. The American Diabetes Association consensus statement applies to both.

Sedation

Quetiapine is more sedating per milligram, particularly at the low doses used off-label for sleep. This is one reason it is so widely prescribed for insomnia — a use the American Academy of Sleep Medicine has cautioned against because of the metabolic and other risks even at low doses.

Movement effects

Both have low rates of extrapyramidal symptoms relative to first-generation antipsychotics. Quetiapine has the lowest EPS rate of nearly any antipsychotic, which is why it is often chosen for patients with Parkinson's disease who develop psychosis.

Orthostatic hypotension and dizziness

Both can cause this, particularly during titration. Quetiapine is often slightly worse at the start because of its alpha-1 affinity.

Cardiac and other

Both have a small risk of QT-prolongation; quetiapine's risk may be marginally higher at high doses. See our QT prolongation explainer.

Dosing flexibility

Quetiapine's dose ranges across indications stretch from 25 mg (off-label sleep) to 800 mg (schizophrenia). Olanzapine's effective range is narrower — usually 5–20 mg. For prescribers wanting low-dose options for anxiety or augmentation, quetiapine is often used off-label; olanzapine less so.

When olanzapine is the better choice

• Severe or treatment-resistant positive symptoms
• Acute mania needing rapid stabilisation
• History of multiple relapses on other atypicals
• Patient values fewer pills per day (once-daily dosing is well-established)

When quetiapine is the better choice

• Bipolar depression (specific approval and strong evidence)
• Patient with Parkinson's disease and psychosis (low EPS risk)
• Significant insomnia accompanying the underlying condition (caution with the low-dose sleep use, however)
• Patient cannot tolerate olanzapine's weight effect but still needs sedation

Cost

Both are widely available as generics and similarly affordable.

This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Information is summarised from publicly available FDA labelling and peer-reviewed literature. Always consult your prescribing clinician before starting, stopping, or changing any medication. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.